Role of IRF4 in IFN-stimulated Gene Induction and Maintenance of Kaposi Sarcoma-associated Herpesvirus Latency in Primary Effusion Lymphoma Cells
Overview
Affiliations
IFN regulatory factor (IRF) 4 is a hematopoietic cell-specific transcription factor that regulates the maturation and differentiation of immune cells. Using an inducible expression system, we found that IRF4 directly induced a specific subset of IFN-stimulated genes (ISGs) in a type I IFN-independent manner in both epithelial and B cell lines. Moreover, Kaposi sarcoma-associated herpesvirus (KSHV)-encoded viral FLICE inhibitory protein (vFLIP) enhances IRF4-mediated gene induction. Coexpression of IRF4 with vFLIP significantly increased ISG60 (IFIT3) and Cig5 (RSAD2) transcription that was dependent on the ability of vFLIP to activate NF-κB. A vFLIP mutant (A57L) defective in NF-κB activation failed to enhance IRF4-mediated ISG induction. Thus, we provide a physiologically relevant mechanism by which viral protein-mediated NF-κB activation modulates specific ISG induction by IRF4. In contrast, IRF4 also acted as a negative regulator of KSHV replication and transcription activator expression after induction of KSHV lytic reactivation in KSHV-positive primary effusion lymphoma cells. Taken together, these results suggest a dual role for IRF4 in regulating ISG induction and KSHV lytic reactivation in primary effusion lymphoma cells.
IFIT3: a crucial mediator in innate immunity and tumor progression with therapeutic implications.
Wu R, Yang H, Liu C Front Immunol. 2025; 16:1515718.
PMID: 40061935 PMC: 11885914. DOI: 10.3389/fimmu.2025.1515718.
Chang L, An Z, Zhang J, Zhou F, Wang D, Liu J Mol Ther Nucleic Acids. 2021; 24:622-633.
PMID: 33981480 PMC: 8076647. DOI: 10.1016/j.omtn.2021.01.021.
The interplay between EBV and KSHV viral products and NF-κB pathway in oncogenesis.
Charostad J, Nakhaie M, Dehghani A, Faghihloo E Infect Agent Cancer. 2020; 15:62.
PMID: 33072180 PMC: 7559203. DOI: 10.1186/s13027-020-00317-4.
Rodriguez-Carrio J, Lopez P, Alperi-Lopez M, Caminal-Montero L, Ballina-Garcia F, Suarez A Front Immunol. 2019; 9:3085.
PMID: 30666255 PMC: 6330328. DOI: 10.3389/fimmu.2018.03085.
Boeijen L, Hou J, de Groen R, Verbon A, Boonstra A J Virol. 2018; 93(9).
PMID: 30185599 PMC: 6475777. DOI: 10.1128/JVI.00575-18.